Skip to main content

Table 1 Baseline characteristics of patients (N = 247)

From: Prediction of posthepatectomy liver failure using transient elastography in patients with hepatitis B related hepatocellular carcinoma

Variables n (%), mean ± SD, or median (range)
Age (years) 53.3 ± 10.3
Gender (Male /Female) 213/34(86%/14%)
BMI (kg /m2) 29.9 ± 16.5
Complicationsa 43(17%)
Cirrhosis (yes /no) 76/171(30.8%/69.2%)
White blood cell (109/l) 5.2 ± 2.0
Hemoglobin (g/l) 143.9 ± 14.1
Platelet Count (109/l) 145(41–466)
Child–Pugh class A 247
Total bilirubin (umol/l) 16.0 ± 11.8
Albumin (g/l) 41.7 ± 3.3
Prealbumin (mg/l) 238.6 ± 62.6
Alanine transaminase (u/l) 39.2 ± 34.2
Aspartate aminotransferase (u/l) 36.99 ± 31.3
Gamma-glutamyl transpeptidase (u/l) 47(11–866)
Alkaline phosphatase (u/l) 81(34–250)
PT(s) 11.5(9.4–15.4)
INR 1.0(0.8–1.3)-
APTT(s) 27.2(16.7–52.9)
LSM(Kpa) 12.7(3.8–38.5)
Intraoperative blood infusion (yes / no) 19/228(8%/92%)
Portal vein occlusion (yes / no) 194/53(79%/21%)
Esophageal varices (yes / no) 18/229(7.3%/92.7%)
Tumor capsule (yes / no) 174/73(70%/30%)
Number of tumors (Single / multiple) 217/30(88%/12%)
Anti-viral medication(Positive / negative) 71/176(28.7%/71.2%)
HBV DNA levels (>1.0E + 04iu/ml/<1.0E + 04iu/ml) 73/174(30%/70%)
Major hepatectomy 40 (16%)
Median main tumor size(cm) 5.02 ± 3.18
Tumor location (right lobe /left lobe/ both) 158/79/10(64%/32%/4%)
  1. aComplications include one or more of the following: hypertension, heart disease (myocardial ischemia, cardiomyopathy, arrhythmia), chronic obstructive pulmonary disease, diabetes, etc.